Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-059381
Filing Date
2013-11-18
Accepted
2013-11-18 07:58:59
Documents
1
Period of Report
2013-11-14

Document Format Files

Seq Description Document Type Size
1 rrd395580.html 4  
1 rrd395580.xml 4 13792
  Complete submission text file 0001181431-13-059381.txt   15011
Mailing Address
Business Address
SANDELL SCOTT D (Reporting) CIK: 0001237289 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 131225484

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations